Summary

In North America Drug screening, otherwise known as drug testing, is performed in various cases, such as when patients are unconscious and cannot tell what drug they have taken earlier. Drug tests are also done for patients to identify which drugs they are allergic to and in cases of known drug allergic conditions with pain management. The testing process involves collecting various samples, including skin, hair follicles, blood, saliva, and urine. Various factors, including increased population, increased medicine, healthcare, infrastructure, rise in chronic diseases, and rise in intake of drugs by patients, contribute to the growth of the drug screening market. The increase in patients who are allergic to some compositions of drugs also increases market size. In North America For various religious reasons, the ban on substances and drugs is seen. In such cases, the drug screening process is performed in terms of substance abuse. People in this region are more aware of drug screening policy increases market size. In North America growing demand for safety rules and regulations in every place and increasing drug, alcohol, and substance abuse is significant growth driving factors for the North America drug screening market in developed countries. Government initiatives for a ban on drugs of abuse and an increase in fundraising activities and awareness of healthy lifestyle activities positively impact the market and increase the market growth. Many employers in North America use drug screening as a standard part of the hiring process. Pre-employment drug testing is common, especially in safety-sensitive industries, to ensure a drug-free workplace. The legalization of recreational and medical marijuana in various states has posed challenges for drug testing. Employers must navigate the balance between maintaining a drug-free workplace and respecting employees' rights in states where marijuana use is legal. Drug testing is widespread in North American sports leagues, including the National Football League (NFL), Major League Baseball (MLB), and the National Basketball Association (NBA). Athletes are regularly tested for performance-enhancing drugs and banned substances.

According to the research report "North America Drug Screening Market Outlook, 2028," published by Bonafide Research, the drug screening market was valued at USD 3 Billion in 2022. The opioid epidemic and other substance abuse problems in North America may drive increased demand for drug screening services. Employers, healthcare providers, and government agencies may intensify efforts to address substance abuse issues, leading to a higher demand for drug testing. Some employers may integrate drug testing as part of comprehensive workplace wellness programs. This approach focuses not only on identifying substance abuse issues but also on addressing the root causes through employee assistance programs and counselling. Some drug testing programs may include screening for prescription medications, especially in industries where the use of certain drugs could pose safety risks. This approach acknowledges the potential impact of legal medications on workplace safety. Companies may offer more comprehensive drug testing panels that cover a broader range of substances, including designer drugs and synthetic opioids. Staying ahead of emerging drug trends is crucial for ensuring the effectiveness of testing programs. Employers may take a holistic approach to employee well-being, considering mental health alongside substance abuse issues. Drug testing programs might be complemented by mental health initiatives and support services. AI applications in drug testing could lead to improved accuracy in result interpretation and more efficient screening processes. AI algorithms may help analyse complex data sets, reducing the risk of false positives or negatives. The industry may witness a growing emphasis on environmentally sustainable practices, including the development of eco-friendly drug testing kits and disposal methods.

Based on country the market is divided into United States, Canada and Mexico. In the United States, drug screening is deeply entrenched in employment practices, with a substantial emphasis on pre-employment testing across diverse industries. The on-going trend of marijuana legalization for medical and recreational use in several U.S. states has prompted a revaluation of drug testing policies, with employers navigating the delicate balance between maintaining a drug-free workplace and respecting individual rights in jurisdictions where marijuana use is legal. The Department of Transportation (DOT) plays a significant role in shaping drug testing policies, particularly in safety-sensitive industries. Canada, with its own evolving legislative landscape regarding marijuana legalization, similarly grapples with reconciling workplace drug testing policies with changing social norms. Meanwhile, in Mexico, drug screening practices are influenced by the country's unique regulatory environment and the on-going efforts to address substance abuse issues. Technological advancements, including the adoption of rapid testing solutions, integration with electronic health records, and the exploration of artificial intelligence applications, are key trends shaping the market across all three countries. Cross-industry collaborations and the integration of block chain technology for secure record-keeping are indicative of the market's forward-looking approach.

The market is categorized into Consumables, Analytical Instruments, Rapid Testing Devices and Drug Screening Service. The consumables segment is leading the market based on Product and Service. The consumables segment may experience a high level of competition, leading to product innovation and competitive pricing. Companies may invest in developing and promoting consumables to gain a larger market share, further propelling the growth of this segment. The availability of over-the-counter drug testing kits for personal or parental use contributes to the growth of the consumables market. This accessibility enhances the overall market size as individuals and families purchase these products. Drug testing is not limited to workplaces; it is also prevalent in other settings such as schools, sports, and healthcare institutions. The consumables segment caters to the diverse needs of drug screening outside traditional workplaces, expanding its market reach. Public health campaigns and initiatives to address substance abuse may lead to an increased demand for drug testing. Consumables play a vital role in supporting these campaigns by providing the tools needed for effective screening. Consumables suppliers may offer customizable solutions and package deals, providing organizations with flexibility in choosing the components that best suit their needs. This flexibility can contribute to the popularity of the consumables segment.

Based on sample type the market is categorized into Urine Samples, Breath Samples, Hair Samples, Oral Fluid Samples and Other Samples. The Oral Fluid Samples segment in the North American drug screening market is poised for significant growth due to its advantages in terms of convenience, accuracy, and non-invasiveness. Oral fluid testing can offer results within minutes, making it ideal for situations requiring quick turnaround times, such as roadside sobriety checks or pre-employment screening. Collecting oral fluid samples is simple and can be done with minimal training. This makes it suitable for on-site or unsupervised testing. Oral fluid is less prone to tampering or adulteration compared to urine samples, enhancing the integrity and reliability of test results. Innovations in oral fluid testing devices and methodologies are improving accuracy, sensitivity, and the range of detectable drugs. The increasing use of prescription opioids has fuelled concerns about addiction and misuse. Oral fluid testing is becoming a preferred tool for pain management clinics to monitor patients and ensure adherence to medication regimens. Companies are increasingly recognizing the importance of a drug-free work environment to prevent accidents and improve productivity. Oral fluid testing offers a convenient and reliable way to achieve this.

In terms of end user the market is segmented into Laboratories, Workplaces, Hospitals and Others. The number of patients admitted to hospitals is steadily increasing due to various factors like an aging population, chronic disease prevalence, and improved access to healthcare. This larger patient pool naturally translates into a higher demand for drug screening services. Tracking medication adherence, detecting substance abuse early for intervention, and preventing adverse drug interactions. Hospitals are increasingly adopting advanced drug screening technologies, such as rapid immunoassays and mass spectrometry, to achieve faster, more accurate, and wider-ranging detection of drugs. This technological shift fuels market growth for both instruments and consumables used in such testing. Regulatory bodies are mandating drug screening in hospitals for specific situations, like pre-transplant evaluation or pain management programs. This compliance requirement creates a guaranteed market for drug screening services and products. Hospitals prioritize patient safety and quality care. Drug screening plays a crucial role in achieving this by identifying potential risks and preventing harm caused by drug use, intoxication, or withdrawal. This focus on safety further drives the adoption of drug screening services.

Companies Covered in this report:

Abbott Laboratories, Laboratory Corporation , Drägerwerk AG & Co. KGaA, Siemens Healthineers, Shimadzu Corporation , OraSure Technologies, Quest Diagnostics, Lifeloc Technologies, Inc.

Considered in this report

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• North America Drug screening market Outlook with its value and forecast along with its segments
• Country-wise Drug screening market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product and Service

• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type

• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User

• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Drug screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.




***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents